Pathogenicity characteristics of stocked and fresh yeasts strains

Brazilian Journal of Microbiology

Volumn 34, Issue 3, 2003, Pages 197-202

  Chaves, Guilherme Maranhão ^a   De Queiroz Cavalcanti, Maria Auxiliadora ^a,c   Figueiredo Porto, Ana Lúcia ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Centro de Ciências Biológicas   (Brazil)

^c DEPARTAMENTO DE MICOLOGIA   (Brazil)

Author keywords

Pathogenicity; Phospholipase; Proteinase; Temperature; Yeasts

Indexed keywords

EID: 19944420515     PISSN: 15178382     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1517-83822003000300003     Document Type: Article

References (39)

1. Barnett, J.A.; Payne R.W.; Yarrow D. Yeasts: characteristics and identification. 4 ed. Cambridge, Cambridge: University Press, 1990, 1002p.
2. Bistoni, F.; Vecchiiarelli, A.; Cenci, A.; Sbaraglia, G.; Perito, S.; Cassone, A. A comparision of experimental pathogenicity of Candida species in cyclophophamide-immunodepressed mice. Sabouraudia, 22:409-418, 1984.
3. Borg-von, M.; Grünes, V. Characterization of two monoclonal antibodies against secretory proteinase of Candida tropicalis DSM 4238. J. Med. Vet. Mycol., 21:1-15, 1993.
4. Borg-von, M.; Meyer, I.; Thomssen, R.; Wurzner R.; Sanglard D.; Monod HIV-Protease inhibitors reduce cell adherence of Candida albicans by inhibition of yeast secreted aspartic proteases. J. Invest. Dermat., 113(5):747-751, 1999.
5. Candido, C.C.; Azevedo, R.V.P.; Komesu, M.C. Enzimotipagem de espécies do gênero Candida isoladas da cavidade bucal. Rev. Soc. Bras. Med. Trop., 33(5):437-442, 2000.
6. Chakrabarti, A.; Nayak, N.; Talwar, P. In vitro proteinase production by Candida species. Mycopathologia, 141:163-168, 1991.
7. Coleman, D.C.; Rinaldi, M.G.; Haynes, K.A; Rex, J.H.; Summerbell, R.C.; Anaisse, E.J.; Li, A.; Sullivan, D.J. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med Mycol, 36:156-165, 1998.
8. De Bernardis, F.; Morelli, L.; Ceddia, T.; LorenzenI, R.; Cassone, A. Experimental pathogenicity and acid proteinase secretion of vaginal isolates of Candida parapsilosis. J. Med. Vet. Mycol., 28:125-137, 1990.
9. Ghannoum, M.A. Potential role of phospholipases in virulence and fungal pathogenicity. Clin. Microb. Ver., 13(1):122-143, 2000.
10. Gruber, A.; Berlit, J.; Speth, C.; Lass-Florl; Kofler, G.; Nagl, M.; Borg Von Zepelin, M.; Dierich, M.P.; Wurzner R. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors. Immunobiology, 201(1):133-144, 1999.
11. Hsu, C.F.; Wang, C.G.; Hung, C.S.; Cheng, S.N., Chen, Y.H.; Chu, M.L. Trichosporon beigelli causing oral mucosit and fungaemia: report of one case. Chung Hua Min Kuo Hsiao Erh Ko I Hsiteh Hui Tsa Chih, 39(3):191-194, 1998.
12. Hube, B.; Turver, C.J.; Odds, F.C.; Eiffert, H.; Boulnois, G.J.; Köchel; H.; RücheL, R. Sequence of the Candida albicans gene enconding the secretory aspartate proteinase. J. Med. Vet. Mycol., 29:129-132, 1991.
13. Khozel, T.R. Virulence factors of Cyptococcus neoformans. Trends Microbiol., 3:295-299, 1995.
14. Krcmery, V.Jr.; Mateicka, F.; Kunova, A. Spanik, S.; Giarfas, J.; Sycova, Z.; Trupl, J. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Support Care Cancer, 7(1):39-43, 1999.
15. Kreger-Van RIJ, N.J.W. The yeast: a taxonomic study. 3.ed. Elsevier Sci. Publication: Amsterdan, 1984.
16. Kwon Chung; Bennet. Med. Mycol., 615. 1992.
17. a ed., São Paulo: Sarver-EDUSP, 1991. 695p.
18. Leighton, T.J.; Doi, R.H. The relationship of serine proetease activity to RNA polymerase modification and sporulation in Bacillus subtillis. J. Molec. Biol., 76:103-122, 1973.
19. Lodder, J. The Yeast: a taxonomic study. Oxford: North Holland Publishing Company, 1970. 1385p.
20. Mago, K. Subcellular localisation of enzymes of phospholipase metabolism in Candida albicans. J. Med. Vet. Mycol., 28:355-362, 1990.
21. Mayser, P.; Laabs, S.; Heuer, K.; Gründer, K. Detection of extracellular phospholipase activity in Candida albicans and Rhodotorula rubra. Mycopathologia, 135:149-155, 1996.
22. Mcdonald, F.; Odds, F.C. Virulence for mice of a proteinase secreting strain of Candida albicans and proteinase deficient mutant. J. Gen. Microbiol., 129:431-438, 1983.
23. Milan, E.P.; Malheiros, E.S.; Fischman, O.; Colombo, A.L. Evaluation of the auxacolor system for the identification of clinical yeasts isolates. Mycopathologia, 137:153-157, 1997.
24. MilenwskI, S.; MigninI, F.; CovellI, I.; Borowsky, E. Specific inhibition of acid proteinase secretion in Candida albicans by LYS-NVA-FMDP. J. Med. Vet. Mycol., 32:1-11, 1994.
25. Neder, R.N. Microbiologia: Manual de Laboratório. São Paulo, ed. Nobel, 98p, 1992.
26. Oliveira, E.E.; Silva, S.C.; Soares, A.J.; Attux, C.; Cruvinel, B.; Silva, M.R.R. Toxinas killer e produção de enzimas por Candida albicans isoladas da mucosa bucal de pacientes com câncer. Rev. Bras. Med. Trop., 31:523-527, 1998.
27. Pichova, I; Pavlickova, L; Dostal, J; Dolejsi, E; Hruskova- Heidingsfeldova, O; Weber, J; Ruml, T.; Soucek, M. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors. Eur. J. Biochem., 268(9):2669-2677, 2001.
28. Price, M.F.; Wilkinson, I.D.; Gentry, L.O. Plate Method for detection of phospholipase activity in Candida albicans. Saboraudia, 20:7-14, 1982.
29. a ed., México: Copyright, 1990, 855p.
30. RücheL, R. A variety of Candida proteinases and their possible targets of proteolytic attack in the host. Zbl. Bakt. Mikrob. Hyg., 257(2):266-274, 1984.
31. RucheL, R.; Boning, B.; Borg, M. Characterisation of a secretory proteinase of Candida parapsilosis and evidence for the absence of enzyme during infection in vitro. Infect. Immun., 56:411-419, 1986.
32. Samaranayake, L.P.; Raeside, J.M.; Macfarlane, T.W. Factors affecting the phospholipase activity of Candida species in vitro. J. Med. Vet. Mycol., 22:201-207, 1984.
33. Samuels, K.D.Z.; Heale, J.B.; Lewellyn, M. Characteristics relating to the patogenicity of Metarhizium anisopliae, toward Nilaparvata lugens. J. Invertebr. Pathol., 53:25-31, 1989.
34. Shimizu, M.T. Fosfolipase em espécies de Candida. Rev. Microbiol., 20:338-341, 1989.
35. a ed., Rio de Janeiro: Guanabara Koogan, 1999, 287p.
36. a ed., USA, Commonwealth Mycological Institute, 1983, 51p.
37. Vidotto, V.; Sinnico, A; Di Fraia, D.; Cardaropoli, S.; Aoki, S.; Ito-Kuwa, S. Phospholipase activity in Criptococcus neoformans. Mycopathologia, 126:119-123, 1996.
38. Willis, A.M.; Coulter, W.A.; Fulton, C.R.; Hayes, J.R.; Bell, P.M.; Lamey, P.J. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabete mellitus. Oral Surg., 91(3):317-321, 2001.
39. Wu, T; Saramanayake, L.P. The expression of secreted aspartyl proteinases of Candida species in human whole saliva. J. Med. Microbiol., (8):711-720, 1999.